These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26921515)

  • 1. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.
    Fangueiro JF; Calpena AC; Clares B; Andreani T; Egea MA; Veiga FJ; Garcia ML; Silva AM; Souto EB
    Int J Pharm; 2016 Apr; 502(1-2):161-9. PubMed ID: 26921515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
    Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
    Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release profile and transscleral permeation of triamcinolone acetonide loaded nanostructured lipid carriers (TA-NLC): in vitro and ex vivo studies.
    Araújo J; Garcia ML; Mallandrich M; Souto EB; Calpena AC
    Nanomedicine; 2012 Aug; 8(6):1034-41. PubMed ID: 22115598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
    Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
    Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of resveratrol, Vitamin E, and epigallocatechin gallate loaded lipid nanoparticles for skin care applications.
    Chen J; Wei N; Lopez-Garcia M; Ambrose D; Lee J; Annelin C; Peterson T
    Eur J Pharm Biopharm; 2017 Aug; 117():286-291. PubMed ID: 28411056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanochemoprevention with therapeutic benefits: An updated review focused on epigallocatechin gallate delivery.
    Yang QQ; Wei XL; Fang YP; Gan RY; Wang M; Ge YY; Zhang D; Cheng LZ; Corke H
    Crit Rev Food Sci Nutr; 2020; 60(8):1243-1264. PubMed ID: 30799648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Gemcitabine and Epigallocatechin-3-Gallate Loaded Solid Lipid Nanoparticles on Benzopyrene Induced Lung Cancer Model Via Intranasal Route: Improved Pharmacokinetics and Safety Profile.
    Mishra M; Verma R; Sharma A; Kumar K; Chawla R
    AAPS PharmSciTech; 2024 Jul; 25(6):176. PubMed ID: 39085673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
    Ramesh N; Mandal AKA
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies.
    Kaur H; Kumar B; Chakrabarti A; Medhi B; Modi M; Radotra BD; Aggarwal R; Sinha VR
    Curr Drug Deliv; 2019; 16(1):59-65. PubMed ID: 30255756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
    Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
    J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
    Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model.
    Cano A; Ettcheto M; Chang JH; Barroso E; Espina M; Kühne BA; Barenys M; Auladell C; Folch J; Souto EB; Camins A; Turowski P; García ML
    J Control Release; 2019 May; 301():62-75. PubMed ID: 30876953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
    Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
    Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage.
    Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G
    Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of arginine-glycine-aspartic acid-modified biopolymeric nanoparticles containing epigalloccatechin-3-gallate for targeting vascular endothelial cells to inhibit corneal neovascularization.
    Chang CY; Wang MC; Miyagawa T; Chen ZY; Lin FH; Chen KH; Liu GS; Tseng CL
    Int J Nanomedicine; 2017; 12():279-294. PubMed ID: 28115846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bombesin conjugated solid lipid nanoparticles for improved delivery of epigallocatechin gallate for breast cancer treatment.
    Radhakrishnan R; Pooja D; Kulhari H; Gudem S; Ravuri HG; Bhargava S; Ramakrishna S
    Chem Phys Lipids; 2019 Nov; 224():104770. PubMed ID: 30965023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the permeability and activities of epigallocatechin gallate by quaternary ammonium chitosan/fucoidan nanoparticles.
    Huang TW; Ho YC; Tsai TN; Tseng CL; Lin C; Mi FL
    Carbohydr Polym; 2020 Aug; 242():116312. PubMed ID: 32564860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo studies of ocular topically administered NLC for the treatment of uveal melanoma.
    Cimino C; Sánchez López E; Bonaccorso A; Bonilla L; Musumeci T; Badia J; Baldomà L; Pignatello R; Marrazzo A; Barbaraci C; García ML; Carbone C
    Int J Pharm; 2024 Jul; 660():124300. PubMed ID: 38851409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.